Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy.

Nanbu, Tadafumi; Yotsukura, Akihiko; Suzuki, George; Takekawa, Hiroyuki; Tanaka, Yuki; Yamanashi, Katsuma; Tsuda, Masaya; Yoshida, Izumi; Sakurai, Masayuki; Ashihara, Takashi

Nanbu, Tadafumi; Yotsukura, Akihiko; Suzuki, George; Takekawa, Hiroyuki; Tanaka, Yuki; Yamanashi, Katsuma; Tsuda, Masaya; Yoshida, Izumi; Sakurai, Masayuki; Ashihara, Takashi.

Afiliación

Nanbu T; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Yotsukura A; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Suzuki G; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Takekawa H; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Tanaka Y; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Yamanashi K; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Tsuda M; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Yoshida I; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Sakurai M; Department of Cardiovascular Medicine Hokko Memorial Hospital Sapporo-shi Japan.
Ashihara T; Department of Medical Informatics and Biomedical Engineering Shiga University of Medical Science Seta Tsukinowa-cho, Otsu Japan.

J Arrhythm ; 39(3): 327-340, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37324754

Palabras clave

ablation; atrial fibrillation; rotors; sodium channel blocker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Arrhythm Año: 2023 Tipo del documento: Article